Actively Recruiting
Strategies to Improve Well-Being and Diabetes Management
Led by Elizabeth Scharnetzki · Updated on 2025-09-03
150
Participants Needed
1
Research Sites
135 weeks
Total Duration
On this page
Sponsors
E
Elizabeth Scharnetzki
Lead Sponsor
M
MaineHealth
Collaborating Sponsor
AI-Summary
What this Trial Is About
This project aims to implement an adapted self-affirmation intervention among a population of individuals with diabetes to reduce the negative psychosocial impacts of stigma. In a self-affirmation, participants are guiding through a writing exercise writing designed to reinforce sources of self-worth before they encounter or engage in stressful or stigmatizing events. Participants in this study will be asked to complete self-affirmation exercises before their 3-month wellness appointments with their endocrinologists over the course of a year. The main questions the investigators are asking are: * Will self-affirmation reduce feelings of stigmatization? * Will self-affirmation increase self-efficacy and motivation to engage in condition management behaviors. * Will self-affirmation improve blood glucose control. Participants will be randomly assigned to either the intervention condition or a waitlist control condition. Participants in the waitlist control condition will also complete writing exercises but they will be abbreviated (this in the psychological literature is referred to as a "low affirmation condition"). At the end of the study, waitlist control participants will have access to the full exercise should they like to receive it. After each appointment and self-affirmation, participants will complete surveys assessing feelings of stigma and motivation to engage in condition management. All participants will already be using continuous glucose monitors. The investigators will compare both survey responses and continuous glucose data between our conditions to assess the efficacy of the self-affirmation intervention.
CONDITIONS
Official Title
Strategies to Improve Well-Being and Diabetes Management
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants must be at least 18 years old
- Have a diagnosis of type 2 diabetes (T2D)
- Currently use a continuous glucose monitor (Dexcom, FreeStyle Libre) as part of their diabetes management
- Be a patient of MaineHealth Endocrinology and Diabetes
You will not qualify if you...
- Individuals under 18 years of age
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
MaineHealth Institute for Research, Center for Interdisciplinary and Population Health Research
Westbrook, Maine, United States, 04092
Actively Recruiting
Research Team
E
Elizabeth Scharnetzki
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here